Spectator on facebook

Spectator on facebook

CORPORATE NEWS

Slovakofarma tabs Nomura for stock issue

Officials from the capital investment department of Slovakofarma Inc ., the largest Slovak pharmaceutical producer, announced in the second week of May that Nomura International Plc. will be the lead manager of the Hlohovec-based firm's 230.8 million Sk GDR issue.

The GDR issue, expected to be launched in September, will mark the first international stock issue of a private company from the Slovak Republic, officials said, adding the GDRs will be issued through raising Slovakofarma's equity by 15 - 20 percent.

Slovakofarma posted a 1996 net profit of 512.9 million Sk. According to a company spokesman, overall turnover at the firm for 1996 was 4.97 billion Sk, up from 4.34 billion Sk in 1995.

Top stories

Slovak scientist in the US: Slovak science needs more than just money to thrive

It seems as if we do not want skilled scientists to return home, says Dominika Truban, who founded a platform connecting Slovak researchers abroad and at home.

Dominika Truban

The Education Ministry to restore the analytical institute

The institute that is part of the Value for Money initiative was merged with another body at the beginning of the year.

Education Minister Martina Lubyová

Blog: Helping others helps your company too

Tatiana Čaplová, Program Coordinator for CSR at the Pontis Foundation, offers a very interesting look behind the scenes of the most successful CSR event in Slovakia - Naše Mesto (Our City).

Bratislava